Skip Navigation

infoSIDA logo

 
Home > Drugs > KP-1461

KP-1461
Drug Class: Nucleoside Reverse Transcriptase Inhibitors
KP-1461, also known as SN1461 and SN1212, is a type of medicine called a nucleoside analogue. KP-1461 works by introducing changes to HIV's genetic makeup that eventually kill the viral particles.

HIV/AIDS-Related Uses
KP-1461 is an investigational medicine that is not yet approved by the FDA for use outside of clinical trials. It is being studied for the treatment of HIV-1 infection. This medicine does not cure or prevent HIV infection or AIDS and does not reduce the risk of passing the virus to other people.

Dosage Form/Administration
KP-1461 is taken by mouth.

Contraindications
Individuals should tell a doctor about any medical problems before taking this medicine.

Possible Side Effects
Along with its desired effects, KP-1461 may cause some unwanted effects. Not all of these effects are known; further study is needed to identify side effects.

Drug and Food Interactions
A doctor should be notified of any other medications being taken, including prescription, nonprescription (over-the-counter), or herbal medications.

Clinical Trials
Click here to search ClinicalTrials.gov for trials that use KP-1461.

Manufacturer Information
KP-1461
  Koronis Pharmaceuticals
  12277 134th Court NE, Suite 110
  Redmond,  WA  98052
  (425) 825-0240
    
Updated February 13, 2008